...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Why now?

,,,well,,I hope one of the friends hit the number on this company,,,,that $20 USD would set us up for life as is,,,,my Zenith shares are spin out shares,,,and well into the 10s of thousands,,,,so I only need one hit from DMcC,,and if he does a deal even near that number the wife says she will take Don into her own hands if you catch my drift!!!!,,Bring it on Ohhh DonnieĀ  Boy McC.......let some shaft out big guy!!!!..Pull the trigger.....it wont be soon enuff for me to get out.....and if I ever hear the names Resverlogix or Zenith Capital in my life time it would be much tooo soon!,,,,,,,,,,,,,,,,,,,,,

Share
New Message
Please login to post a reply